FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
GRIFFITH FOODS LTD
- Product
- Item 25293502, ADHESION BREADER EX, 50 lb. bag
- Reason
- potential for pieces of metal in product
- Published
- December 25, 2024
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
GRIFFITH FOODS LTD
- Product
- Item 79588401, ITAL STY PD HERB REDUCED EX, 55 lb. bag
- Reason
- potential for pieces of metal in product
- Published
- December 25, 2024
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
GRIFFITH FOODS LTD
- Product
- Item 18968101, 100138 ITALIAN MBALL DRY MIX EX, 40.84 lb. ba…
- Reason
- potential for pieces of metal in product
- Published
- December 25, 2024
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
GRIFFITH FOODS LTD
- Product
- Item 42081001, 104023600 SPICY BREADING EXPORT, 50 lb. bag
- Reason
- potential for pieces of metal in product
- Published
- December 25, 2024
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass I
Fabalish,
- Product
- Fabalish Inc. , Kickin, Carrot Falafel , 10oz , Cardboard t…
- Reason
- Potential E Coli contamination.
- Published
- December 25, 2024
- Distribution
- Multiple states
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
Impossible Foods Inc
- Product
- Impossible Spicy Ground Sausage Meat from plants 14oz chub,…
- Reason
- product may contain pieces of metal
- Published
- December 25, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Terminated
Historical recordClass II
Impossible Foods Inc
- Product
- Impossible Savory Ground Sausage Meat from plants 14oz chub,…
- Reason
- product may contain pieces of metal
- Published
- December 25, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-040-20
by Mylan Institutional, Inc.
- Reason
- Subpotent and Superpotent Drug
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-445-20
by Mylan Institutional, Inc.
- Reason
- Subpotent and Superpotent Drug
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-041-20
by Mylan Institutional, Inc.
- Reason
- Subpotent and Superpotent Drug
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20
by Mylan Institutional, Inc.
- Reason
- Subpotent and Superpotent Drug
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 42292-039-20
by Mylan Institutional, Inc.
- Reason
- Subpotent and Superpotent Drug
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20
by Mylan Institutional, Inc.
- Reason
- Subpotent and Superpotent Drug
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60
by Ascend Laboratories, LLC
- Reason
- CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60
by Ascend Laboratories, LLC
- Reason
- CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-count bottles (NDC 0378-1811-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
by Viatris Inc
- Reason
- Superpotent Drug and Subpotent Drug: potency failures obtained
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
by Viatris Inc
- Reason
- Superpotent Drug and Subpotent Drug: potency failures obtained
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
by Viatris Inc
- Reason
- Superpotent Drug and Subpotent Drug: potency failures obtained
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count bottles (NDC 0378-1805-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
by Viatris Inc
- Reason
- Superpotent Drug and Subpotent Drug: potency failures obtained
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
Historical recordClass II
Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count bottles (NDC 0378-1803-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
by Viatris Inc
- Reason
- Superpotent Drug and Subpotent Drug: potency failures obtained
- Published
- December 18, 2024
- Distribution
- Nationwide
View recall →
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions.
Read the full medical disclaimer.